Figure S1: Doses Given and DLTs Experienced in the Dose Escalation and Dose Expansion Cohorts from A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER+/HER2− Advanced Breast Cancer
openalex(2023)
关键词
Alpha Particle Therapy,Neoadjuvant Therapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要